Discover

Your trusted source for GLP-1 research, news, and patient insights.

Compounded medications

4 posts in this category

What is a shortage?

We’ve all been hearing about the shortage of tirzepatide or semaglutide, but what is a shortage? How does it impact compounding?

Dec 28, 2024

FDA: Tirzepatide Shortage is over, again!

The FDA has ended the shortage for tirzepatide, essential copy compounding ends on Feb 18 and March 19

Dec 19, 2024

FDA Warns Against Unapproved GLP-1 Drugs for Weight Loss

The FDA issued a warning about counterfeit Ozempic, research peptides and retatrutide . Medications should be prescribed and filled with state licensed pharmacies

Dec 18, 2024

image showing Outsourcing Facilities Association, et al., Plaintiffs, v. U.S. Food and Drug Administration, et al., Defendants. Case No. 4:24-cv-00953-P JOINT STATUS REPORT

Nov 21 Update on Compounded Tirzepatide Availability and Ongoing FDA Reevaluation

OFA vs FDA Case Join report Nov 21

Nov 21, 2024